Advancing innovative vascular solutions
With a proven stent platform and innovative drug-eluting technology, we are revolutionizing endovascular solutions for dialysis access and peripheral artery disease (PAD).
Our vision is clear
To deliver groundbreaking, evidence-based solutions that extend the patency of dialysis access grafts, fistulas and peripheral arteries enabling patients to lead healthier lives with fewer interventions.
Our Products
We will transform vascular care with cutting-edge, next generation electrospinning PTFE covered stent grafts, already proven in global markets with more than 13,000 units sold to date.
Meeting Critical Needs in Dialysis Access and PAD Treatment
We are dedicated to bringing advanced technology to market that will improve the lives of patients with ESKD (End Stage Kidney Disease) and PAD (Peripheral Artery Disease).
“Solaris Endovascular’s advanced covered stent platforms will not only reduce the burden of repeated interventions but will also dramatically enhance the quality of life and life expectancy for those who suffer from these debilitating conditions.”
-Dr. Marco Costa, Chief Scientific & Medical Officer
Partner with us to redefine patient outcomes for hemodialysis access and PAD.
Investors
Discover the innovative technology driving Solaris Endovascular and the opportunities it presents for growth and impact.
Physicians
Access clinical insights and see how Solaris Endovascular can improve outcomes for your patients.
Distributors
Understand how to partner with Solaris Endovascular.
Contact Us
Partner with us to redefine patient outcomes for hemodialysis access and PAD.
201 St. Charles Ave, Suite 2500
New Orleans, LA 70170